n-acetylsphingosine has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, D; Dong, M; Feng, M; Guan, Z; Jiang, S; Kuerban, K; Li, J; Peng, Y; Wang, Q; Ye, L | 1 |
| Hu, XS; Lv, XW; Shi, JP; Wang, J | 1 |
| Berthier, F; Kushner, I; Lozanski, G | 1 |
3 other study(ies) available for n-acetylsphingosine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Flow Cytometry; Humans; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sorafenib; Sphingosine; TOR Serine-Threonine Kinases | 2017 |
Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Liver Neoplasms; PPAR gamma; Signal Transduction; Sphingosine | 2007 |
The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen.
Topics: Apolipoproteins; Bridged-Ring Compounds; C-Reactive Protein; Carcinoma, Hepatocellular; Ceramides; Fibrinogen; Humans; Interleukin-1; Interleukin-6; Norbornanes; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine; Thiocarbamates; Thiones; Tumor Cells, Cultured | 1997 |